“…Less attention was paid to the possibility of using bone seeking radiopharmaceuticals for assessing the response to therapy of osseous metastases, although radioactivity uptake of metastatic bone lesions has been found to be diminished after irradiation (2,4,7,8), chemotherapy and/or hormonal treatment (3,5,6,10,11,12,13). Work published on this subject has not yet clarified completely the type of scintigraphic changes to be expected in responding patients, because unchanged positive scintigrams were also found during successful treatment of osseous metastases (1,9) and initially, during the first months, some authors even registered an increased uptake after therapy which was followed by a gradual decline (4, 6, 7).…”